Why did MBIO plummet?

The stock price of MBIO has experienced a significant drop on July 1, 2025, which can be attributed to the following factors: 1. **Recent Performance**: Mustang Bio's stock has been volatile, with a significant increase of 114.64% on July 1, 2025, followed by a decline of 20.48% in the post-market session. This volatility could be due to market reactions to recent news or earnings reports. 2. **Clinical Trial Data**: The company's stock saw a significant boost on April 23, 2025, after announcing promising data from their latest clinical trials. However, the recent decline might reflect a correction after the initial excitement wore off. 3. **Financial Position**: Mustang Bio's financial position has been challenging, with a loss of $951,000 indicated by the EBIT and a cash position of $6,839,000. The company has been expending $664,000 on research and development, which could be a factor in the market's perception of its financial health and future prospects. In conclusion, the decline in MBIO's stock price can be attributed to a combination of factors including its volatile performance, market correction after initial excitement about clinical trial data, and its challenging financial position. |code|Ticker|Name|Date|Percentage Change|market_code| |---|---|---|---|---|---| |MBIO|MBIO.O|Mustang Bio|20250616|-5.1282|186| |MBIO|MBIO.O|Mustang Bio|20250617|-8.1081|186| |MBIO|MBIO.O|Mustang Bio|20250618|4.902|186| |MBIO|MBIO.O|Mustang Bio|20250620|-1.8692|186| |MBIO|MBIO.O|Mustang Bio|20250623|-1.9048|186| |MBIO|MBIO.O|Mustang Bio|20250624|4.8544|186| |MBIO|MBIO.O|Mustang Bio|20250625|-4.6296|186| |MBIO|MBIO.O|Mustang Bio|20250626|0|186| |MBIO|MBIO.O|Mustang Bio|20250627|-0.9709|186| |MBIO|MBIO.O|Mustang Bio|20250630|-6.3627|186|